Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLI-F06 for Wound Healing and Scar Appearance in Abdominoplasty
NCT03880058Phase 2Completed
- Sponsor
- Scarless Laboratories, Inc.
- Start
- Mar 2019
- Primary completion
- May 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Severe cutaneous adverse drug reactions (SCARs) comparing SLI-F06 Side with Vehicle Side (2 arms). Primary endpoint: Patient and Observer Scar Assessment Scale - PI Assessment at 3 months. Started Mar 2019; status: completed.
02
Drugs
SLI-F06
03
Conditions
Severe cutaneous adverse drug reactions (SCARs)
Beyond the preview
Go deeper on NCT03880058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03880058.